chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Localized - inflamed red heated area. Pt saw her physician and was given cephalexin 500 mg.
She has a crummy taste in her mouth feels like metallic or metal, it feels weird.; Nothing taste good; On day 3, after the injection she had horrible smell like burnt wood or oranges. Smells it with anything cooked. Anything she eats has that same smell anything that's cooked.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient received bnt162b2 (BNT162B2), administration date 25Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "COVID-19", start date: 11Nov2020 (unspecified if ongoing), notes: mild case. On day 10 of having COVID 19 she lost her sense of taste and smell. She gained back 85 percent of her taste came back; "lost her sense of taste and smell", start date: 21Nov2020 (unspecified if ongoing), notes: She gained back 85 percent of her taste came back but, still did not get back smell back at all until just recently; "lost her sense of taste and smell", start date: 21Nov2020 (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PAROSMIA (non-serious) with onset 28Mar2021, outcome "unknown", described as "On day 3, after the injection she had horrible smell like burnt wood or oranges. Smells it with anything cooked. Anything she eats has that same smell anything that's cooked."; DYSGEUSIA (non-serious), outcome "unknown", described as "She has a crummy taste in her mouth feels like metallic or metal, it feels weird."; TASTE DISORDER (non-serious), outcome "unknown", described as "Nothing taste good". The action taken for bnt162b2 was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Arm soreness, dizziness, headache, body aches. Went to the ER for dizziness that was so bad I couldn't walk, wanted to make sure it wasn't a delayed allergic reaction. At ER  they did an EKG (normal result), then received  ibuprofen (21:30), acetaminophen (22:45), meclizine (22:45). Was discharged at 23:03.
Treatment of COVID-19; Treatment of COVID-19; Dose 1,  Dose 2, Dose 3, Dose 4= Moderna, Dose 5=Pfizer/BioNTech; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 72-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 05Oct2022 as dose 5 (booster), single (Lot number: GH9703) at the age of 72 years for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 04Mar2021 as dose 1, single (Lot number: 027A21A), on 01Apr2021 as dose 2, single (Lot number: 028A21A), on 23Oct2021 as dose 3 (booster), single (Lot number: 027C21A) and on 09Apr2022 as dose 4 (booster), single (Lot number: 001M21A) for covid-19 immunisation. The patient's relevant medical history included: "Diabetes" (unspecified if ongoing); "Lymphocytic colitis" (unspecified if ongoing); "Hypertension" (unspecified if ongoing); "High cholesterol" (unspecified if ongoing), notes: High cholesterol. The patient's concomitant medications were not reported. Past drug history included: Vicodin, reaction(s): "Allergy_Vicodin", notes: Allergy_Vicodin. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 05Oct2022, outcome "unknown", described as "Dose 1, Dose 2, Dose 3, Dose 4= Moderna, Dose 5=Pfizer/BioNTech"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Dec2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Dec2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 and received Paxlovid, from 03Dec2022 to 08Dec2022
One day after vaccine I developed irregular heart beats and shortness of breath.  In general not feeling well.  Fatigued. This lasted for almost 2 weeks.
Circular Large raised itchy rash. Bruise in center. Painful and  warm to touch. Located immediately below the injection site. Still present four days later.
Patient states about 4 to 5 hours after immunization he started feeling body aches and and migraine type headache. Over the next 2 days had small blister like bumps around the injection on his left arm. He states it looked like they were filled with fluid or pus. Patient went to his family doctor on Friday 8/17/12 to be checked out. Doctor told him it like he got a live virus shot. Doctor prescribe a Zithromycin Z-pak and rest. I talked to patient on Sunday 8/19/12 to follow up with him from his first discussion with the other pharmacist on Friday 8/17/12. He stated he is starting to fell better.
Patient reported coughing and shortness of breath 1 hour after Covid vaccine.Pulse Ox 99%, lungs clear, P 88, cough noted. Patient given 25mg oral Benadryl. Coughing subsided
Patient came today at 10:42am today for a consultation and asking to report to VAEARS for her adverse reaction.  She got Moderna Booster on Friday of 1/21/22.  On the night of 1/21/22, she starting to experience nasal congestion, sneezing, running nose, her injection site was red, very itchy, raised harden bump on the injection site pain, and the border of the red swollen area diameter keep getting bigger everyday.  She have been taking benadryl everyday (still taking it up until today) and apply ice on the injection site area, and it did help alleviated most of the symptoms.  Patient is very concern and insisted on marking on her profile of having allergic reaction to Moderna due to the severe itchiness on her injection site.
On 2/7/01 the pt was presented to the ER with a febrile seizure.
This spontaneous report was received from an office manager and refers to a patient of unknown age and gender. On 06-AUG-2017 the patient was vaccinated with an expired VAQTA lot # M031695 with expiration date 26-MAY-2017 for prophylaxis. Not adverse event was reported.
Pt woke up @ 2AM w/temp of 105; responded to APAP & H2O bath immersion;
After giving the shot pt was advised to wait 15 mins so our pharmacy team can monitor him to make sure there is no allergic reactions to the vaccine. Patient was fine and was able to walk into the waiting area by himself after receiving the shot. About 2 mins later, patient's wife asked for the pharmacist's attention to check on the patient. Patient stated that he felt light headed and was about to pass out, and pharmacist on duty immediately called 911.  Paramedic checked on the patient, and patient was able to walk out the store on his own after 15 mins.
I had sore throat and headache for the first two days. Then I had congestion and fatigue for the next 5 days. Then the congestion started to break after a week, and all the symptoms started to gradually reduce after week. I took over the counter cold medication, acetaminophen, and ibuprofen. I also had head fog.
nurse accidentally pulled ipv up instead of ppd solution and administered it in left forearm 0.01 ml intradermal. then realized entering the lot # that it was ipv not ppd. nurse drew ppd solution and administered it in right forearm 0.01 ml intradermal. pt to return to clinic 7/19/19.
Within 2 days had body ache felt like buss hit me.  After  a week my left arm started hurting and chest tight.  Went to ER and was diagnosed with inflammation of chest wall and  told that vaccination probably causing issues as ekg, blood test and xray came back fine.  After 2nd dose including prior issues I have heart fluttering.
7PM 20MAR95 noted spots on arms & legs, abd, face;a few more appeared on 21MAR95 & pt cranky, feet & ankles swelled last noc;PE on 22MAR97 revealed target lesions on thigh multiple differing sized red mac pap & crying-raised red lesion;
Symptoms started on Monday when the test site of my arm was extremely sore and I had a mild headache. Tuesday I started getting additional symptoms of respiratory symptoms with a runny nose and cough, chills, and headache.
13 x 9 cm on (L) thigh & 9 x 9 cm on (R) thigh cluster of flesh-colored pinpoint papules & tiny vesicles on a pink base.
10/26/06 - 11pm started to feel achy. 10/27/06 - R arm hurting, edema from elbow to axilla. Arm red/hot to touch. Fever 101. 10/27/06- Seen at clinic; Rx Augmentin given. 10/30/06 - Edema resloved, no temperature.
Patient was bitten by a dog after she received the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ANIMAL BITE (Patient was bitten by a dog after she received the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Hernia. Concomitant products included DOXYCYCLINE for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ANIMAL BITE (Patient was bitten by a dog after she received the vaccine). At the time of the report, ANIMAL BITE (Patient was bitten by a dog after she received the vaccine) outcome was unknown.            No concomitant medication information was provided. No treatment medication were provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Follow-up information received on 08-Jul-2021 contains no new information.
General fatigue, feeling slightly unable to speak or text in clear sentences (i.e., patient said she feels "loopy"), coughing for a little while, chest (lungs) feels heavy
Deep aching joints, hands and elbows. Red, swollen feet and ankles. Diagnosed at ER as Vasculitis. Reg. Dr. Said it was a severe reaction to the shot. I have residual weakness in my leg muscles and a frozen shoulder from where the shot was administered. One of the warning of the toxoid for tetanus hsould be if allergic to horses DO NOT take this shot.
The day of the shot a few hours from 12:30 p.m. on April 15, 2021 I started to get headaches A few hours later after that which was around 7 or 8 o'clock p.m. I started to vomit uncontrollably And now every time that I drink any type of liquid or any type of food I vomit it backup and doesn't stop vomiting until 30 minutes to 40 minutes after With painful headaches and coughing
From physician note on 9/11/15: Pt came to clinic per my request to check his (L) arm. He received pneumonia vaccine on 9/8/15. Noticed redness yesterday. No pain. Exam: (L) posterior upper arm; + red, warm area with induration at center, + a red streak toward anterior arm. + tattoo on anterolateral (L) upper arm. Doxycycline 100 mg BID.
Constipation &  bad menstrual cycle after 1st shot.; Constipation &  bad menstrual cycle after 1st shot.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 23Mar2021 12:00 (Lot number: ER8732) at the age of 41 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Chronic constipation" (unspecified if ongoing); "Allergies: Allergic to contrast dye, red dyes" (unspecified if ongoing); "Allergies: milk products" (unspecified if ongoing); "Allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: LINZESS; L-LYSINE ACETATE; FLAX OIL. The following information was reported: MENSTRUAL DISORDER (non-serious), CONSTIPATION (non-serious), outcome "not recovered" and all described as "Constipation &  bad menstrual cycle after 1st shot.". Therapeutic measures were not taken as a result of menstrual disorder, constipation.  Additional information: Facility type vaccine: Pharmacy or Drug Store. Patient did not received covid prior vaccination. Patient did not covid tested post vaccination. Patient did not received any other vaccine in four weeks. Patient stated that Since her 2nd shot 2 weeks ago, her heart rate and body temp are elevated. She was hot all the time and can't sleep well, so she was tired. she also had her 1st herpes outbreak in 9 months.  No follow-up attempts are possible. No further information is expected.
pt recv vax;low grade fever of 103;patches on inside of lower lips;MD felt fever probably due to immunization or cutting a tooth;also v & shaking;discharge summary read:r/o viral synd Vs immunization;
My menstrual cycle stopped after vaccine for Covid. We did find my prolactin level is high. Then in June, Previous diagnosis, I begin having inflammation in my bladder and  Interstitial Cystitis. I'm reduced to using a cane and have disposable diapers.
Patient tensed prior to giving shot. Shot was administered. He was fine. After giving shot, pharmacist was notified that he has passed out during shot administration. Patient wasn't feeling well. Pharmacist asked patient to remain seated. He started passing out. He passed out and came back to. Was given food and drink and sat for 15 minutes. Patient was fine and was able to leave pharmacy unassisted with father.
huge red blatch; huge red blatch, kind of itchy; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), RASH MACULAR (huge red blatch) and RASH PRURITIC (huge red blatch, kind of itchy) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 39K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 18-Jan-2021, the patient experienced RASH MACULAR (huge red blatch) and RASH PRURITIC (huge red blatch, kind of itchy). At the time of the report, PAIN IN EXTREMITY (Sore arm), RASH MACULAR (huge red blatch) and RASH PRURITIC (huge red blatch, kind of itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient just put ice in the zone.
rheumatoid like pain (extreme) in all joints; shakes; swollen hands/ swelling under left arm; weakness in the legs; muscle spasm; Stomach upset; unable to walk with body upright; chills; fever; extreme headache; Pain in muscles and joints; nausea; extreme muscle pain/ pain in muscles and joints; This is a spontaneous report from a contactable pharmacist. This pharmacist (patient) reported for herself that a 45-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Ff2589) at the age of 45-years, via an unspecified route of administration in left arm on 07Oct2021 at 18:00 at single dose for COVID-19 immunization, at pharmacy/drug store. Medical history included high blood pressure. No known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not pregnant at time of vaccination. Concomitant medications included olmesartan medoxomil (BENICAR) and gabapentin (GRALISE). The patient historically received first single dose of BNT162B2 (lot number: 301308a) at the age of 45-years via an unspecified route of administration in left arm on 15Sep2021 at 12:00 PM for COVID-19 immunization. On 08Oct2021 at 12:00, the patient had extreme muscle pain, shakes, chills and fever, swollen hands, weakness in the legs, extreme headache, muscle spasm that feels like she was beaten. Swelling under left arm. Pain in muscles and joints. Stomach upset and nausea. Unable to walk with her body upright and rheumatoid like pain (extreme) in all joints. AE treatment included paracetamol (TYLENOL) 500 mg. Outcome of the events was recovered with lasting effects. Since the vaccination, the patient has not been tested for COVID-19.; Sender's Comments: Based on the information in the case report and a plausible temporal relationship, a possible causal association between the event rheumatic disorder and suspect drug BNT162B2 cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Discharge Provider: MD Primary Care Provider at Discharge: MD   Admission Date: 3/29/2023 Discharge Date:  4/4/2023  PRESENTING PROBLEM: Syncope and collapse [R55] Syncope, unspecified syncope type [R55] Anemia, unspecified type [D64.9]   HOSPITAL COURSE: ? 58 y.o. male with past medical history significant for cardiomyopathy, chronic combined CHF with recovered EF, AFib/flutter s/p cryoablation on eliquis (2017), sick sinus syndrome s/p dual chamber AICD (2020), coronary artery disease s/p CABG (2020), hypertension, hyperlipidemia, PAD s/p BLE bypass, history of orthostatic hypotension, chronic neck pain on opioids and history of tobacco use disorder (> 100 pack years) who presented to the ED due to dyspnea and syncopal events.   ? In the ED, his hgb was 8.1 which is down from 11 in 11/2022. He  noticed intermittent episodes of formed, black stool as well as intermittent darker red blood in stool that turns toilet bowel rust colored. He was admitted to facility 7/2022 with episode of syncope in setting of BRBPR, dehydration, AKI, hyponatremia and orthostatic hypotension. His hgb remained stable in 10-11 range, so he was discharged with plan for outpatient EGD / Colonoscopy which he never completed. In ED he was mildly hypertensive, temp 37.8°, heart rate 70s-80s, respirations 18 and O2 98% on room air.  Labs notable for sodium 128, hemoglobin 8.1, NT proBNP 7808, troponin 28 with a repeat of 29. Chest x-ray shows mild central vascular congestion without confluent infiltrates or effusions.  Patient admitted to medical floor, tested positive for COVID-19 noted to be on 2 L of oxygen, started on dexamethasone and remdesivir. During the hospital course patient was noted to have nonsustained V-tach for which Cardiology was consulted and recommended conservative management optimization of medications and electrolytes. Patient was started on metoprolol. He finished a five day course of remedesivir and was weaned to RA. EGD done on 4/2 showed no acute findings, colonoscopy done on 4/2 showed multiple large colon polyps. Biospy results pending. GI recommends repeat colonoscopy in 3-6 months. GI will follow bxs. Eliquis was resumed. Patient was found to be iron deficient and given IV iron and started on oral supplements.  He finished a five day course of doxycycline. Dizziness resolved prior to discharge. Patient was medically stable when discharged.
Inflammatory immune response; Vasculitis; Suffering paresthesia since 2 days after my 1st dose of COVID-19 vaccine.; Small fiber neuropathy; This is a spontaneous report received from a contactable consumer (patient). A 51-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 1 administered in Arm Left on 25May2021 (Lot Number: EW0183) at age of 51-year-old as 1ST DOSE,SINGLE for covid-19 immunisation. Medical history included known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's concomitant medications received within 2 weeks of vaccination was fexofenadine. The patient suffering paresthesia since 2 days after her 1st dose of COVID-19 vaccine -now on day 12. A neurologist has diagnosed her with an inflammatory immune response causing small fiber neuropathy and possible vasculitis.  Events onset date was 26May2021. AE resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Treatment received. The outcome was Not recovered. No COVID prior vaccination. No COVID tested post vaccination.
Almost immediate soreness in right arm extending up shoulder and  along right side of neck. Soreness in arm subsided after a few days.  However, pain in right side of neck is still present after over 2 months, and is not alleviated by ibuprofen or acetaminophen.
Pt Was admitted on 08/16/2021 Still in the hospital tested positive on 08/16/2021. Pt was admitted with 2 days of diarreah , fatigue, Weakness, dizzyness and difficulty breathing with a pulse ox. of 81%. Pt was Place on high flow Nasal cannula at 40% o2. On Solumedrel and completed Remdesivir on 8/21. Given one dose actemra Given on 8/17.
Received vaccination on Tuesday afternoon and felt fine until Tuesday evening around 8:00-8:30 PM when client reports that he first developed a scratchy throat and a cough which he describes and deep and hacking. He had chills off and on until about 9:00 PM when the intermittent chills developed into a constant chills/shaking and sweating. It was at this point that client reports he took an ALKA-SELTZER Cold and Flu OTC medicine and proceeded to fall asleep. He awoke at midnight and the chills were gone but he had body aches. The next morning he felt tired and worn out and had a lingering cough which proceeded to last throughout the day on Wednesday, 10/19/2016. He reports that his symptoms have completely resolved today.
headache; weakness; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and ASTHENIA (weakness) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0412L20A and 0412L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced HEADACHE (headache) and ASTHENIA (weakness). At the time of the report, HEADACHE (headache) and ASTHENIA (weakness) outcome was unknown.